Table: Fuji Pharmaceutical -2023/24 parent results

Fuji Pharma

12/11/2024 07:02

Nov 12 (Reuters)- 
          Fuji Pharmaceutical  Co Ltd 
          PARENT-ONLY FINANCIAL HIGHLIGHTS 
     (in billions of yen unless specified)
                 Year ended      Year ended       Year to     NEXT     
              Sep 30, 2024    Sep 30, 2023   Sep 30, 2025     YEAR     
                 LATEST         YEAR-AGO        COMPANY      COMPANY   
                 RESULTS         RESULTS       FORECAST    H1 FORECAST 
  Sales           41.93           37.42          49.24        24.12    
               (+12.0 pct)     (+15.0 pct)    (+17.4 pct)  (+23.8 pct) 
  Revenues                                        4.19         2.10    
                                              (+22.1 pct)   (+5.7 pct) 
  Operating        3.43            3.46                                
               (-0.8 pct)      (+0.1 pct)                              
  Recurring        3.95            4.07           4.03         2.05    
               (-2.9 pct)      (+19.9 pct)    (+1.9 pct)    (-1.8 pct) 
  Net              5.81            3.12           2.90         1.45    
               (+86.4 pct)     (+25.7 pct)    (-50.0 pct)  (-66.6 pct) 
  EPS          238.94 yen      128.27 yen     119.32 yen    59.97 yen  
  Ann Div       42.50 yen       37.00 yen      45.50 yen               
  -Q2 Div       20.00 yen       17.00 yen      20.00 yen               
  -Q4 Div       22.50 yen       20.00 yen      25.50 yen               
  
  NOTE - Fuji Pharmaceutical  Co Ltd. 
  To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4554.T